These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36470209)

  • 1. CD72-semaphorin3A axis: A new regulatory pathway in systemic lupus erythematosus.
    Eiza N; Sabag AD; Kessler O; Neufeld G; Vadasz Z
    J Autoimmun; 2023 Jan; 134():102960. PubMed ID: 36470209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A regulatory role for CD72 expression on B cells in systemic lupus erythematosus.
    Vadasz Z; Haj T; Balbir A; Peri R; Rosner I; Slobodin G; Kessel A; Toubi E
    Semin Arthritis Rheum; 2014 Jun; 43(6):767-71. PubMed ID: 24461079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Truncated-semaphorin3A is a potential regulatory molecule to restore immune homeostasis in immune-mediated diseases.
    Eiza N; Kessler O; Sabag A; Neufeld G; Jones EY; Vadasz Z
    Front Pharmacol; 2022; 13():1085892. PubMed ID: 36703747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD72 negatively regulates B lymphocyte responses to the lupus-related endogenous toll-like receptor 7 ligand Sm/RNP.
    Akatsu C; Shinagawa K; Numoto N; Liu Z; Ucar AK; Aslam M; Phoon S; Adachi T; Furukawa K; Ito N; Tsubata T
    J Exp Med; 2016 Nov; 213(12):2691-2706. PubMed ID: 27810925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semaphorin 3A - a marker for disease activity and a potential putative disease-modifying treatment in systemic lupus erythematosus.
    Vadasz Z; Toubi E
    Lupus; 2012 Oct; 21(12):1266-70. PubMed ID: 22875653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD72 is an inhibitory pattern recognition receptor that recognizes ribosomes and suppresses production of anti-ribosome autoantibody.
    Akatsu C; Tsuneshige T; Numoto N; Long W; Uchiumi T; Kaneko Y; Asano M; Ito N; Tsubata T
    J Autoimmun; 2024 Jun; 146():103245. PubMed ID: 38754236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Urine Secretion of Semaphorin3A in Lupus Patients with Proteinuria.
    Doron R; Merav L; Nasrin E; Adi SD; Elias T; Gleb S; Itzhak R; Michael R; Zahava V
    Inflammation; 2022 Apr; 45(2):603-609. PubMed ID: 34562225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD72, a coreceptor with both positive and negative effects on B lymphocyte development and function.
    Wu HJ; Bondada S
    J Clin Immunol; 2009 Jan; 29(1):12-21. PubMed ID: 19067131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human CD72 splicing isoform responsible for resistance to systemic lupus erythematosus regulates serum immunoglobulin level and is localized in endoplasmic reticulum.
    Hitomi Y; Adachi T; Tsuchiya N; Honda Z; Tokunaga K; Tsubata T
    BMC Immunol; 2012 Dec; 13():72. PubMed ID: 23268649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased mutations of CD72 transcript in B-lymphocytes from adolescent patients with systemic lupus erythematosus.
    Kaneko U; Toyabe S; Hara M; Uchiyama M
    Pediatr Allergy Immunol; 2006 Dec; 17(8):565-71. PubMed ID: 17121583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging role of semaphorin-3A in autoimmune diseases.
    Liu LN; Li XM; Ye DQ; Pan HF
    Inflammopharmacology; 2018 Jun; 26(3):655-665. PubMed ID: 29696565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semaphorin-3A,
    Liu LN; Wang P; Zou YF; Xu Z; Cheng J; Zhang Y; Hu W; Pan HF
    Autoimmunity; 2019 Jun; 52(4):161-167. PubMed ID: 31394943
    [No Abstract]   [Full Text] [Related]  

  • 13. Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus.
    Vadasz Z; Haj T; Halasz K; Rosner I; Slobodin G; Attias D; Kessel A; Kessler O; Neufeld G; Toubi E
    Arthritis Res Ther; 2012 Jun; 14(3):R146. PubMed ID: 22697500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The B-cell transmembrane protein CD72 binds to and is an in vivo substrate of the protein tyrosine phosphatase SHP-1.
    Wu Y; Nadler MJ; Brennan LA; Gish GD; Timms JF; Fusaki N; Jongstra-Bilen J; Tada N; Pawson T; Wither J; Neel BG; Hozumi N
    Curr Biol; 1998 Sep; 8(18):1009-17. PubMed ID: 9740800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased soluble CD72 in systemic lupus erythematosus is in association with disease activity and lupus nephritis.
    Vadasz Z; Goldeberg Y; Halasz K; Rosner I; Valesini G; Conti F; Perricone C; Sthoeger Z; Bezalel SR; Tzioufas AG; Levin NA; Shoenfeld Y; Toubi E
    Clin Immunol; 2016 Mar; 164():114-8. PubMed ID: 26883681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased Expression of Semaphorin 3A and Semaphorin 7A Levels and Its Association with Systemic Lupus Erythematosus.
    Wang P; Mao YM; Liu LN; Zhao CN; Li XM; Pan HF
    Immunol Invest; 2020 Feb; 49(1-2):69-80. PubMed ID: 31412748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40 and CD72 expression and prognostic values among children with systemic lupus erythematosus: a case-control study.
    Asmiyou A; Bakr AM; Shahin DA; Wahba Y
    Lupus; 2020 Sep; 29(10):1270-1276. PubMed ID: 32700598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semaphorin3A: A Potential Therapeutic Tool for Lupus Nephritis.
    Bejar J; Kessler O; Sabag AD; Sabo E; Itzhak OB; Neufeld G; Vadasz Z
    Front Immunol; 2018; 9():634. PubMed ID: 29670620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory B cell co-receptors and autoimmune diseases.
    Tsubata T
    Immunol Med; 2019 Sep; 42(3):108-116. PubMed ID: 31532707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease.
    Xu M; Hou R; Sato-Hayashizaki A; Man R; Zhu C; Wakabayashi C; Hirose S; Adachi T; Tsubata T
    J Immunol; 2013 Jun; 190(11):5436-45. PubMed ID: 23616572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.